Kymera targets protein degradation to treat lymphoma by Arlene Weintraub Wednesday, June 19, 2019 In mice, Kymera's lead drug promoted tumor regression, both on its own and in combination with BTK inhibitor Imbruvica.
New discoveries in Lyme disease and cancer—News of Note by Arlene Weintraub Monday, February 5, 2018 The past week ushered in discoveries that could inspire new treatments for Lyme disease and several cancers.
Redx sells cancer drug to Loxo to escape debt crisis by Nick Paul Taylor Monday, July 31, 2017 The $40 million deal was put together by the insolvency firm Liverpool council called in to recoup a loan and rescue Redx.
